Female sexual dysfunction following gynaecologic cancer treatment in Hospital Tengku Ampuan Afzan

• Main Author: Ahmad, Tuan Norhanani Tuan
• Format: Thesis
• Language: English
• Published: 2023
• Subjects: R Medicine; RC254-282 Neoplasms. Tumors. Oncology (including Cancer); RG Gynecology and obstetrics
• Online Access: http://eprints.usm.my/62866/

OBJECTIVE: Sexual dysfunction is highly prevalent in gynaecological cancer patients. Determining the risk factors of sexual dysfunction in cancer patients enables us to pay more attention to those who are vulnerable and to device strategies for early detection, prevention and treatment of sexual dysfunction in them. The main aim of the study was to determine the prevalence of sexual dysfunction and its associated factors in gynaecological cancer patients in Hospital Tengku Ampuan Afzan, Kuantan, Pahang. STUDY METHOD: This cross sectional study involved gynaeoncology patients in Hospital Tengku Ampuan Afzan who fit the inclusion criteria for this study. They will be evaluated by using Malay Version of Female Sexual Function Index (MVFSFI). It is 19 item questionnaire that assess sexual functioning in women in 6 separate domains. Data were analysed using univariate analyses and logistic regression analysis to look for prevalence and factor associated with Female Sexual Dysfunction. RESULT: Sexual dysfunction in gyaneoncology patients following treatment is 63.2% FSD is most observed in patient with cervical cancer (83%). Age and education level have significant association with having sexual dysfunction problems. Women of a year older has 1.325 odds ratio to have sexual dysfunction problems (95% CI: 1.201, 1.461, p-value <0.001). Women who did not pursue tertiary education has 1.884 odds ratio of having sexual dysfunction problems compare to those who complete until tertiary education (95% CI: 1.054, 3.364, p-value 0.032). Patients who underwent surgery and chemotherapy has 0.343 times the odds and patients who only underwent surgery as treatment has 0.123 times the odds of having FSD when compared to those who received CCRT as treatment. CONCLUSION: Sexual dysfunction is one of the common side effects following gynaecological cancer treatment and this study shows the prevalence is high and there are other associated factors that also involved.